Diagnosis of a pheochromocytoma

American Journal of the Medical Sciences

Volumn 329, Issue 1, 2005, Pages 18-21

  Westphal, Sydney A ^a  

^a MARICOPA MEDICAL CENTER   (United States)

Author keywords

Adrenal tumor; Hypertensive crisis; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CATECHOLAMINE;

CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CHEMICAL ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; RADIODIAGNOSIS; REVIEW; TUMOR LOCALIZATION;

EID: 11844303549     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200501000-00004     Document Type: Review

References (28)

1. Cryer PE. Diseases of the sympathochromaffin system. In: Felig P, Frohman LA, editors. Endocrinology and metabolism, 4th ed. New York (NY): McGraw-Hill; 2001. p. 525-551.
2. Stein PP, Black H. A simplified diagnostic approach to pheochromocytoma. Medicine 1990;70:46-66.
3. Bravo EL, Gifford RW Jr. Pheochromocytoma: diagnosis, localization, and management. N Engl J Med 1984;311:1298-1303.
4. Plouin P-F, Degoulet P, Tugayé A, et al. Le dépistage du phéochromocytome: chez quels hypertendus? Etude sémiologique chez 2585 hypertendus dont 11 ayant un phéochromocytome. Nouv Presse Med 1981;10:869-72.
5. Walther MM, Reiter R, Keiser HR, et al. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 1999;162:659-64.
6. Eisenhofer G, Walter MM, Huynh TT, et al. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 2001;86:1999-2008.
7. Sawka AM, Jaeschke R, Singh RJ, et al. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003;88:553-8.
8. Lenders JWM, Pacak K, Walther MM, et al. Biochemical diagnosis of a pheochromocytoma: which test is best? J Am Med Assoc 2002;287:1427-34.
9. Eisenhofer G. Biochemical diagnosis of pheochromocytoma: is it time to switch to plasma-free metanephrines? [editorial] J Clin Endocrinol Metab 2003;88:550-2.
10. Eisenhofer G, Goldstein DS, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true from false-positive test results. J Clin Endocrinol Metab 2003;88:2656-66.
11. Sawka AM, Gafni A, Thabane L, et al. The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocrinol Metab 2004;89:2859-66.
12. Young WF. Pheochromocytoma and hyperaldosteronism: diagnostic approaches. Endocrinol Metab Clin North Am 1997;26:801-27.
13. Sheps SG, Jiang N-S, Klee GG, et al. Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc 1990;65:88-95.
14. Wortsman J, Frank S, Cryer PE. Adrenomedullary response to maximal stress in humans. Am J Med 1984;77:779-84.
15. Cryer PE. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 1980;303:436-44.
16. Rolih CA, Ober KP. The endocrine response to critical illness. Med Clin North Am 1995;79:211-24.
17. Golub MS, Tuck ML. Diagnostic and therapeutic strategies in pheochromocytoma. Endocrinologist 1992;2:101-5.
18. Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 2004;89:479-91.
19. Pacak K, Linehan WM, Eisenhofer G, et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001;134:315-29.
20. Werbel SS, Ober KP. Pheochromocytoma: update on diagnosis, localization, and management. Med Clin North Am 1995;79:131-53.
21. Khafagi FA, Shapiro B, Fig LM, et al. Labetolol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 1989;30:481-9.
22. Mannelli M. Diagnostic problems in pheochromocytoma. J Endocrinol Invest 1989;12:739-57.
23. Manger WM, Gifford RW. Pheochromocytoma: current diagnosis and management. Cleve Clin J Med 1993;60:365-78.
24. Bouloux P-MG, Fakeel M. Investigation of pheochromocytoma. Clin Endocrinol 1995;43:657-64.
25. Francis IR, Korobkin M. Pheochromocytoma. Radiol Clin North Am 1996;34:1102-12.
26. Koonce DH, Pollack BE, Glassy FJ. Bilateral pheochromocytoma associated with neurofibromatosis. Am Heart J 1952;44:901-9.
27. Rossip, Young IS, Panke WF. Techniques, usefulness, and hazards of arteriography of pheochromocytoma. JAMA 1968;205:75-81.
28. Brueckel J, Boehm BO. Crisis after angiography. Lancet 1998;352:1278.